Sequanta selects Olink® Explore 3072 to analyze new cohort study in China
SHANGHAI, Jan. 25, 2022 /PRNewswire/ -- Olink Holding AB (publ) (Nasdaq: OLK) today announced that Sequanta Technologies, a leading multi-omics se...
Stay updated with breaking news from Olink Explore. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SHANGHAI, Jan. 25, 2022 /PRNewswire/ -- Olink Holding AB (publ) (Nasdaq: OLK) today announced that Sequanta Technologies, a leading multi-omics se...
Investegate announcements from Olink Proteomics AB, Sequanta selects Olink® Explore 3072 to analyze new cohort study in China
Read independent reviews on Olink® Explore 1536 from Olink Proteomics on SelectScience
Discover key biological insights into risk prediction and breast cancer prevention using population-based proteogenomics
Discover key biological insights into risk prediction and breast cancer prevention using population-based proteogenomics